Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Matsui

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
BMC Biochemistry|May 22, 2016
Tubulin is a molecular target of the Wnt-activating chemical probeYasunori Fukuda, Osamu Sano, Kenichi Kazetani, et al.
FEBS Letters|May 3, 2016
Vacuolin-1 inhibits autophagy by impairing lysosomal maturation via PIKfyve inhibitionOsamu Sano, Kenichi Kazetani, Masaaki Funata, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
A simple and widely applicable hit validation strategy for protein-protein interaction inhibitors based on a quantitative ligand displacement assayTomoya Sameshima, Ikuo Miyahisa, Misaki Homma, et al.
Journal of Synchrotron Radiation|April 25, 2002
High-resolution hard X-ray phase-contrast microscopy with a large-diameter and high-numerical-aperture zone plateYasushi Kagoshima, Yoshiyuki Yokoyama, Takashi Ibuki, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
T-3364366 Targets the Desaturase Domain of Delta-5 Desaturase with Nanomolar Potency and a Multihour Residence TimeIkuo Miyahisa, Hideo Suzuki, Atsushi Mizukami, et al.
Anticancer Research|December 1, 2017
Functional Characterization of VEGF- and FGF-induced Tumor Blood Vessel Models in Human Cancer XenograftsYusaku Hori, Ken Ito, Shusei Hamamichi, et al.
Cancer Medicine|May 8, 2018
Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma modelsMasahiro Matsuki, Taisuke Hoshi, Yuji Yamamoto, et al.
Cancer Investigation|April 23, 2019
Antitumor and Antiangiogenic Activities of Lenvatinib in Mouse Xenograft Models of Vascular Endothelial Growth Factor-Induced Hypervascular Human Hepatocellular CarcinomaYusuke Adachi, Masahiro Matsuki, Hideki Watanabe, et al.
International Journal of Cancer|October 19, 2007
E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibitionJunji Matsui, Yuji Yamamoto, Yasuhiro Funahashi, et al.
Cancer Science|December 3, 2014
Multitargeting strategy using lenvatinib and golvatinib: maximizing anti-angiogenesis activity in a preclinical cancer modelYouya Nakazawa, Satoshi Kawano, Junji Matsui, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
BMC Biochemistry|May 22, 2016
Tubulin is a molecular target of the Wnt-activating chemical probeYasunori Fukuda, Osamu Sano, Kenichi Kazetani, et al.
FEBS Letters|May 3, 2016
Vacuolin-1 inhibits autophagy by impairing lysosomal maturation via PIKfyve inhibitionOsamu Sano, Kenichi Kazetani, Masaaki Funata, et al.
Bioorganic & Medicinal Chemistry Letters|December 3, 2014
A simple and widely applicable hit validation strategy for protein-protein interaction inhibitors based on a quantitative ligand displacement assayTomoya Sameshima, Ikuo Miyahisa, Misaki Homma, et al.
Journal of Synchrotron Radiation|April 25, 2002
High-resolution hard X-ray phase-contrast microscopy with a large-diameter and high-numerical-aperture zone plateYasushi Kagoshima, Yoshiyuki Yokoyama, Takashi Ibuki, et al.
ACS Medicinal Chemistry Letters|September 24, 2016
T-3364366 Targets the Desaturase Domain of Delta-5 Desaturase with Nanomolar Potency and a Multihour Residence TimeIkuo Miyahisa, Hideo Suzuki, Atsushi Mizukami, et al.
Anticancer Research|December 1, 2017
Functional Characterization of VEGF- and FGF-induced Tumor Blood Vessel Models in Human Cancer XenograftsYusaku Hori, Ken Ito, Shusei Hamamichi, et al.
Cancer Medicine|May 8, 2018
Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma modelsMasahiro Matsuki, Taisuke Hoshi, Yuji Yamamoto, et al.
Cancer Investigation|April 23, 2019
Antitumor and Antiangiogenic Activities of Lenvatinib in Mouse Xenograft Models of Vascular Endothelial Growth Factor-Induced Hypervascular Human Hepatocellular CarcinomaYusuke Adachi, Masahiro Matsuki, Hideki Watanabe, et al.
International Journal of Cancer|October 19, 2007
E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibitionJunji Matsui, Yuji Yamamoto, Yasuhiro Funahashi, et al.
Cancer Science|December 3, 2014
Multitargeting strategy using lenvatinib and golvatinib: maximizing anti-angiogenesis activity in a preclinical cancer modelYouya Nakazawa, Satoshi Kawano, Junji Matsui, et al.
Pageof 7